Subscribe

Oneview Healthcare PLC (ONE.AX)

AUD0.17 +0.01 (+3.13%)
IE ASX Healthcare Medical - Healthcare Information Services
Address Blackrock Business Park A94 H2X4
Dublin, IE
CEO James Fitter
Website oneviewhealthcare.com
IPO 2016-03-16
ISIN AU000000ONE9

Explore sections of this company profile

Also trades on Australian Securities Exchange · ONE.AX (AUD) Other OTC · ONVVF (USD)
Description

Oneview Healthcare PLC provides specialized software solutions and expert consulting services to the healthcare industry. Its market reach extends across Ireland, the United States, Australia, Asia, and the Middle East. The company's core offering is its Care Experience Platform (CXP), available in several configurations. CXP Cloud Start allows clients to implement vital digital engagement tools throughout their organizations. CXP Cloud Enterprise empowers patients and their families to communicate virtually with healthcare teams and access educational health resources. For on-premise requirements, CXP Enterprise On-Prem caters to diverse hospital environments, from newly constructed facilities to those with pre-existing legacy infrastructure. Additionally, Oneview Healthcare provides capabilities that include patient and family empowerment, streamlined patient experience management, virtual care delivery, and digital communication features such as door signs and patient communication boards. Founded in 2008, the company maintains its headquarters in Dublin, Ireland.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
AUD0.17 +0.01 (+3.13%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
135.4K
Beta
0.78
Float Shares
762.15M
Free Float %
86.5%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+2.86% +5.88% +5.88% -33.33% -40.98% -54.43% -32.08% -10.89% -51.35% -94.90% -94.23%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.17
Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 1 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
-11.95
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Healthcare Information Services: +14.2%
    +20.6% ★ Q4'25: +38.0% (vs Q4'23)
  • ✗
    EPS growth Medical - Healthcare Information Services: +43.1%
    -3.8% Q4'25: -24.0% (vs Q4'23)
  • ✗
    FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%
    -102.3% Q4'25: -66.2% (vs Q4'23)
  • ✗
    EBIT margin Medical - Healthcare Information Services: +8.8%
    -92.1% Q4'25: -82.8% (vs Q4'23)
  • ✗
    ROIC Medical - Healthcare Information Services: +5.2%
    -1,065.5% Q4'25: -1,838.1% (vs Q4'23)
  • ✗
    Share dilution Medical - Healthcare Information Services: -0.1%
    +11.8% Q4'25: +5.0% (vs Q4'23)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×
    -0.19× Q4'25: -0.11× (vs Q4'23)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.76) × ERP
WACC = 98% × Ke + 2% × Kd (77.2%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Current price: 0.17
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
2 Rev. Ana.
2 EPS Ana. 		Dec 2027
2 Rev. Ana.
2 EPS Ana. 		Dec 2028
2 Rev. Ana.
2 EPS Ana. 		Dec 2029
1 Rev. Ana.
1 EPS Ana.
Revenue
8.99M
est: 9.10M (-1.2%)
5.76M
est: 6.65M (-13.3%)
8.20M
est: 16.69M (-50.9%)
7.10M
est: 4.45M (+59.4%)
7.10M
est: 20.52M (-65.4%)
9.73M
est: 27.71M (-64.9%)
8.92M
est: 8.98M (-0.6%)
9.40M
est: 6.03M (+55.7%)
9.89M
est: 9.70M (+2.0%)
11.93M
est: 12.55M (-4.9%)
13.81M
13.67M – 13.95M
+10.1% YoY
18.71M
18.48M – 18.94M
+35.5% YoY
24.85M
24.57M – 25.14M
+32.8% YoY
33.91M
33.52M – 34.29M
+36.4% YoY
EBITDA
-22.96M
est: -8.48M (-170.7%)
-23.34M
est: -5.94M (-292.8%)
-19.44M
est: -32.32M (+39.9%)
-15.73M
est: -15.24M (-3.2%)
-7.44M
est: -19.27M (+61.4%)
-8.01M
est: -25.83M (+69.0%)
-12.09M
est: -8.37M (-44.5%)
-7.88M
est: -5.48M (-43.9%)
-11.26M
est: -8.81M (-27.8%)
-10.48M
est: -11.39M (+8.0%)
-12.54M
-12.67M – -12.42M
-10.1% YoY
-16.99M
-17.20M – -16.78M
-35.5% YoY
-22.57M
-22.82M – -22.31M
-32.8% YoY
-30.79M
-31.14M – -30.44M
-36.4% YoY
EBIT
-15.98M
est: -8.60M (-85.8%)
-24.07M
est: -8.29M (-190.2%)
-20.20M
est: -28.27M (+28.6%)
-16.82M
est: -15.54M (-8.2%)
-7.60M
est: -16.66M (+54.4%)
-8.10M
est: -26.19M (+69.1%)
-12.19M
est: -8.49M (-43.6%)
-8.37M
est: -5.61M (-49.2%)
-11.36M
est: -9.02M (-26.0%)
-10.99M
est: -11.66M (+5.8%)
-12.84M
-12.97M – -12.71M
-10.1% YoY
-17.39M
-17.60M – -17.17M
-35.5% YoY
-23.10M
-23.36M – -22.84M
-32.8% YoY
-31.51M
-31.87M – -31.15M
-36.4% YoY
Net Income
-16.03M
est: -164.25M (+90.2%)
-25.90M
est: -7.13M (-263.0%)
-20.28M
est: -30.42M (+33.3%)
-16.94M
est: -15.44M (-9.7%)
-9.45M
est: -79.42M (+88.1%)
-8.19M
est: -46.65M (+82.5%)
-10.87M
est: -12.29M (+11.6%)
-8.93M
est: -7.40M (-20.7%)
-10.84M
est: -11.96M (+9.4%)
-12.51M
est: -11.47M (-9.1%)
-7.07M
-7.17M – -6.96M
+38.4% YoY
-3.89M
-4.24M – -3.53M
+45.0% YoY
92.2K
-706.9K – 1.41M
+102.4% YoY
5.65M
5.57M – 5.74M
+6,034.1% YoY
SGA
11.80M
est: 6.43M (+83.5%)
13.82M
est: 5.25M (+163.2%)
11.81M
est: 16.23M (-27.2%)
9.00M
est: 3.15M (+186.0%)
4.99M
est: 14.60M (-65.8%)
5.58M
est: 19.57M (-71.5%)
7.46M
est: 6.34M (+17.6%)
6.20M
est: 4.11M (+50.7%)
7.52M
est: 6.61M (+13.7%)
6.89M
est: 8.55M (-19.4%)
9.41M
9.32M – 9.50M
+10.1% YoY
12.75M
12.59M – 12.90M
+35.5% YoY
16.93M
16.74M – 17.12M
+32.8% YoY
23.10M
22.84M – 23.36M
+36.4% YoY
EPS
-0.33
est: -0.24 (-37.5%)
-0.47
est: -0.36 (-28.9%)
-0.29
est: -0.30 (+2.0%)
-0.12
est: -0.17 (+30.5%)
-0.05
est: -0.12 (+55.8%)
-0.02
est: -0.07 (+72.1%)
-0.02
est: -0.02 (-15.8%)
-0.02
est: -0.01 (-106.7%)
-0.02
est: -0.02 (-27.9%)
-0.02
est: -0.01 (-9.4%)
-0.01
-0.01 – -0.01
+38.4% YoY
-0.01
-0.01 – 0.00
+45.0% YoY
0.00
0.00 – 0.00
+109.1% YoY
0.01
0.01 – 0.01
+1,500.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-28 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-27 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-26 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-25 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-22 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-21 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-20 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-19 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-18 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-15 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-14 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-13 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-12 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-11 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-08 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-07 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-06 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-05 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-04 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-01 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-30 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-29 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-28 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-27 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-24 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-23 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-22 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-21 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-20 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-17 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-16 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-18.54M
OE per share TTM
-0.03
Owner's Yield
-13.42%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
13.7%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
-114.5K
Shares Outstanding
880.79M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
James Fitter Chief Executive Officer & Executive Director 1M male
Darragh Fergal Lyons Chief Financial Officer & Executive Director 463.7K male
Howe Chief Operations Officer — male
Niall O'Neill Chief Product Officer — male
Richard Eibrand Head of Information Security and IT Operations — male
Toni Pettit Chief of Staff & Company Secretary — female
Aoife Meehan Human Resources Director — female
William Hadden Managing Director of ANZ — male
Declan Bright Chief Technology Officer — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Healthcare Information Services